# A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites

> **NCT03475615** · PHASE3 · UNKNOWN · sponsor: **Fudan University** · enrollment: 215 (estimated)

## Conditions studied

- Gastric Cancer
- Stomach Neoplasms

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** Paclitaxel
- **DRUG:** S-1 (Tegafur, Gimeracil and Oteracil Porassium Capsules)

## Key facts

- **NCT ID:** NCT03475615
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-03-16
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 215 (ESTIMATED)
- **Last updated:** 2018-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03475615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03475615, "A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT03475615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*